The Cannabis Review

In this episode, we are joined by Ronit Pinto, the founder and publisher of Honeysuckle, a well-renowned print and digital arts, culture, and lifestyle publication based in New York City. Founded in 2013 the award-winning, women-owned, internationally distributed media house Honeysuckle Media; is an umbrella company for Honeysuckle Magazine, Honey Pot Magazine, and Honeysuckle Girl.

Topics:

1. New York's Nu Wave

2. Intersection of Industries

* Twitter - @TheCannabisRev2

* LinkedIn - @thecannabisreview

* Episode Library - https://www.thecannabisreview.ie

+ https://honeysucklemag.com/

In this episode, we are joined by Dr. Benjamin Caplan. Dr. Caplan is a renowned GP and has recently published his book 'The Doctor-Approved Handbook'. Dr. Caplan is the Chief Medical Officer at CED Clinic. CED Clinic’s mission is to provide a comfortable and professional environment where patients and physicians can openly discuss medicinal cannabis and its benefits. It was founded in order to provide medical services and oversight to individuals seeking cannabis treatment.

* Twitter - @TheCannabisRev2

In this episode, we are joined by Joeri Perneel. Joeri is the CEO of NexGen Europe, Belgium's premier cannabinoid supplier. Based in Belgium, Nexgen is the leading distributor of CBD products in both the recreational and well-being markets. Nexgen distributes a vast range of CBD products from its very own product facility in Belgium. Brands such as Sensy, Jane’s Garden, and Edelweeds all hold a leading position within the Belgian recreational market. In addition, Sensy is the N°1 recreational CBD retail brand in Belgium. With over two decades of experience in business development, Joeri Perneel has made significant contributions to the corporate landscape. His collaborative efforts with blue-chip companies have solidified his reputation as an influential figure in the Belgian business world.

Topics:

1. Overview of Belgium

2. The NexGen Story

* Twitter - @TheCannabisRev2

* LinkedIn - @thecannabisreview

* Episode Library - https://www.thecannabisreview.ie

+ https://nexgeneurope.eu

In this episode, we are joined by Keith Bushfield. Keith is the CEO of Rexis Biotech, a company focused on developing innovative medical technologies. Prior to joining Rexis, Keith held various leadership positions in the biotechnology industry, including executive roles at popular companies such as Biogen and Genentech. Under his guidance, Rexis has made significant strides in the development of new treatments for various diseases, including cancer and neurological disorders.

In this episode, we are joined by Elana Kirsh. Elana is the CEO of The Cannigma. The Cannigma takes an evidence-based approach to every issue surrounding cannabis – from safety to cooking to medical research – and makes all of that information digestible and useful.

In this episode, we are joined by Andrew Ward. Andrew is a Cannabis Copywriter, Journalist, and Content Marketing Specialist. Since 2017, he has been operating his own content marketing firm, helping build brands in and out of the cannabis space. Andrew is also an author. His works include Cannabis Jobs (2019) and The Art of Marijuana Etiquette (2021).

Topics:

1. Cannabis Media Content

2. New York Update

3. Should Hemp Farmers have been allowed to cultivate first in NY?

* Twitter - @TheCannabisRev2

* LinkedIn - @thecannabisreview

* Episode Library - https://www.thecannabisreview.ie

In this episode, we are joined by Dr. Shabnam Sarshar. Dr. Sarshar has a Ph.D. in Pharmaceutical Biology and Phytochemistry from the University of Munster and is a well-renowned Cannabis phytochemical researcher. Dr. Sarshar is passionate about cannabis for women’s health, having founded Laia’s FemBalance, a company that advocates for and encourages women’s health and other rights in Germany and worldwide. With an MBA in addition to a Ph.D., Dr. Sarshar is also a proficient and well-known business expert.

Topics:

1. Cannabis And Women's Health

2. The FemCan Story

* Twitter - @TheCannabisRev2

* LinkedIn - @thecannabisreview

* Episode Library - https://www.thecannabisreview.ie

+ FemCan https://femcan.com

In this episode we are joined by, Alexandre Rizk. Alex has an impressive list of qualifications and experiences. After being a leader in hotel brokerage for 15 years, he is known for his creative strategic capabilities in financing, and managing all the intricacies of brokering hotel properties. He is currently the CEO of Pro Hospitality Group which owns Las Vegas' first cannabis-friendly hotel, The Lexi.

In this episode, we are joined by Loren DeFalco. Loren is a Partner of CB1 Capital and Head of Research. Loren cured himself of epileptic seizures through a regime of CBD and cannabinoids over a decade ago and continued to research ECS through medical journals and scientific developments.

Topics:

1. Opportunities in Medical Cannabis

2. Endocannabinoid Targeted Drugs

* Twitter - @TheCannabisRev2

* LinkedIn - @thecannabisreview

* Episode Library - https://www.thecannabisreview.ie

+ https://www.cb1cap.com/

In this episode, we are joined by André Silva. André is currently working at Merck in the Cannabis, F&B, and Clinical Testing fields. Merck is a leading pharmaceutical company that focuses on research and development in various areas, including cannabis and food and beverage.

Topics:

1. What are the main compounds tested by labs?

2. How do industry providers support research and quality control testing? 3. What are the main roadblocks in the development of the testing market in the E.U.?

* Twitter - @TheCannabisRev2

* LinkedIn - @thecannabisreview

* Episode Library - https://www.thecannabisreview.ie